Cancer clinical trials face several challenges, including patient recruitment, high costs, and complex regulatory requirements. Recruiting a diverse group of participants can be difficult, yet is essential for ensuring the generalizability of the results. The high cost of conducting trials and the intricate logistics involved also pose significant hurdles. Moreover, navigating the regulatory landscape requires substantial expertise and resources.
